Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACP and Hyaluronic Acid for Knee Osteoarthritis
NCT03889925Phase 3Completed
- Sponsor
- Andrews Research & Education Foundation
- Start
- Mar 2019
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of sodium hyaluronate in knee osteoarthritis (OA), sponsored by Andrews Research & Education Foundation. Started Mar 2019; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03889925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03889925.